Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Sepsis-induced neuroinflammation is significantly associated with sepsis-related brain dysfunction. Remimazolam is a novel ultra-short-acting benzodiazepine anesthetic with multiple organ protective effects. However, it is unknown whether remimazolam can ameliorate LPS-induced brain impairment. In this study, Lipopolysaccharide (5 mg/kg, LPS) severely impaired Sprague-Dawley rats spatial learning ability, memory, and cognitive function. However, remimazolam treatment showed a protective effect on LPS-induced cognitive dysfunction. Remimazolam partly reversed LPS-induced splenomegaly, decreased serum cytokine expression, suppressed hippocampal M1 microglial activation, and mitigated oxidative stress injury and neuroinflammation. Electroacupuncture (EA) or PNU282987 treatment improved LPS-induced cognitive dysfunction and also significantly inhibited neuroinflammation and systemic inflammation. However, MLA, ML385, or subdiaphragmatic vagus nerve (SDV) treatment abolished the protective effects of remimazolam. Further mechanistic studies showed that remimazolam induces protective effects by activating subdiaphragmatic vagus nerve target α7nAChR-mediated Nrf2/HO-1 signaling pathway. These results demonstrate that remimazolam can up-regulate α7nAChR, Cyto-Nrf2, HO-1, and cognitive-related (CREB, BDNF, PSD95) protein expressions, suppress M1 microglia, ameliorate neuroinflammation or systemic inflammation, and reverse cognitive dysfunction. Therefore, this study provides insight into a new therapeutic target for the treatment of sepsis-induced cerebral dysfunction. Graphical Abstract
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“α7nAChR agonist remimazolam activates the Nrf2/HO-1 pathway [22]”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [22]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“First, BBB permeability: many promising preclinical targets tend to exhibit poor CNS penetration, requiring doses that may risk peripheral toxicity [12,13,22].”
From Research Advances in the Pathogenesis of Sepsis-Associated Encephalopathy (2026) · cites this paper as [22]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Rudd, K. E., Johnson, S. C., Agesa, K. M., Shackelford, K. A., Tsoi, D., Kievlan, D. R., Colombara, D. V., Ikuta, K. S., Kissoon, N., Finfer, S., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(19)32989-7 · Cited by 7,971
Morris water maze: procedures for assessing spatial and related forms of learning and memory
Vorhees, C. V., & Williams, M. T. (2006) · Nature Protocols · doi:10.1038/nprot.2006.116 · Cited by 4,629
Fleischmann, C., Scherag, A., Adhikari, N. K. J., Hartog, C. S., Tsaganos, T., Schlattmann, P., Angus, D. C., & Reinhart, K. (2016) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201504-0781oc · Cited by 3,548 · cited 1×
“Sepsis affects more than 30 million people worldwide [1].”
BackgroundReview: Systemic inflammation andAlzheimer's disease
Holmes, C. (2013) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2012.01307.x · Cited by 356
Remimazolam: non-clinical and clinical profile of a new sedative/anesthetic agent
Kilpatrick, G. J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.690875 · Cited by 262
Srivastava, P., Tripathi, P. N., Sharma, P., Rai, S. N., Singh, S. P., Srivastava, R. K., Shankar, S., & Shrivastava, S. K. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.11.049 · Cited by 221
Mitochondrial Dysfunction: a Potential Therapeutic Target to Treat Alzheimer’s Disease
Rai, S. N., Singh, C., Singh, A., Singh, M. P., & Singh, B. K. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01945-y · Cited by 212
Tripathi, P. N., Srivastava, P., Sharma, P., Tripathi, M. K., Seth, A., Tripathi, A., Rai, S. N., Singh, S. P., & Shrivastava, S. K. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2018.12.017 · Cited by 209
Yang, N.-N., Yang, J.-W., Ye, Y., Huang, J., Wang, L., Wang, Y., Su, X.-T., Lin, Y., Yu, F.-T., Ma, S.-M., et al. (2021) · Theranostics · doi:10.7150/thno.52574 · Cited by 204 · cited 1×
“EA apparatus (Hwato, Suzhou, China) was connected (0.5 mA and 15 Hz) for 30 min once daily for five consecutive days to stimulate cholinergic anti-inflammatory pathways [16].”
MethodInfluentialSelf-citationParada, E., Egea, J., Buendia, I., Negredo, P., Cunha, A. C., Cardoso, S., Soares, M. P., & López, M. G. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4671 · Cited by 198
Cited by
Choi, J.-W., Im, J. Y., & Balakrishnan, R. (2025) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2025.118299 · Cited by 19
Role of oxidative stress in sepsis: Mechanisms, pathways, and therapeutic strategies
Yang, X., Wen, R., Yang, N., Gao, Y., & Zhang, T. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101452 · Cited by 19
Wang, D., Liu, Z., Zhang, W., Li, S., Chen, Y., Jiang, C., Su, N., Liu, T., Li, X., & Bi, C. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s504371 · Cited by 14
Zhang, X., Huang, K., Wu, Z., Ding, R., Han, J., Zhang, Y., Lu, Y., Lu, Y., & Si, Y. (2025) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2025.108971 · Cited by 14
Xiaoming, X. U. E., Ma, X., Bing, Z. H. A. O., Bo, L. I. U., Zhang, J., Zhao, L., Li, H.-Z., Liu, X., & Zhao, S. (2025) · Minerva Anestesiologica · doi:10.23736/s0375-9393.24.18338-1 · Cited by 12
Metadata
- Authors
- Zhou, Z., Yang, Y., Wei, Y., & Xie, Y.
- Affiliations
- First Affiliated Hospital of GuangXi Medical University (CN)
- Guangxi Medical University (CN)
- Corresponding author
- Xie, Yubo
- Venue
- Neurochemical Research
- Published
- 2024-03-12
- Volume
- 49
- Issue
- 5
- Pages
- 1306-1321
- ISSN
- 0364-3190 (ISSN-L)
- 1573-6903
- PMC
- PMC10991060
- OpenAlex
- W4393953125
- Cited by
- 30
- References
- 37
- Citations by year
- 2026: 12 · 2025: 17 · 2024: 1
- FWCI
- 4.84
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Neurochemical Research (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Special Fund of Neurotoxicity of General Anesthetics and Its Prevention and Treatment Innovation Team of the First Affiliated Hospital of Guangxi Medical University (No. YYZS2022001)
- Guangxi Clinical Research Center for Anesthesiology (No. GK AD22035214)
- the Key Project of Natural Science Foundation of Guangxi (No. 2020GXNSFDA238025)
- Topics
- Life Sciences › Neuroscience › Developmental Neuroscience › Anesthesia and Neurotoxicity Research
- Life Sciences › Neuroscience › Neurology › Vagus Nerve Stimulation Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- remimazolam, lipopolysaccharide, cognitive impairment, alpha7 nicotinic acetylcholine receptor, Nrf2/HO-1 pathway, hippocampus, electroacupuncture, oxidative stress, systemic inflammation, brain-derived neurotrophic factor, CREB, PSD-95
- MeSH terms
- Neuroinflammatory Diseases, Animals, Benzodiazepines, Inflammation, Lipopolysaccharides, Vagus Nerve, Signal Transduction, Rats, Sprague-Dawley, Sepsis, NF-E2-Related Factor 2, Rats, Cognitive Dysfunction, alpha7 Nicotinic Acetylcholine Receptor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. https://app.cochat.ai/papers/10.1007/s11064-024-04115-x
- The paper
- Zhou, Z., Yang, Y., Wei, Y., & Xie, Y. (2024). Remimazolam Attenuates LPS-Derived Cognitive Dysfunction via Subdiaphragmatic Vagus Nerve Target α7nAChR-Mediated Nrf2/HO-1 Signal Pathway. Neurochemical Research. https://doi.org/10.1007/s11064-024-04115-x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.